Sugentech Inc. logo

Sugentech Inc. (253840)

Market Open
7 Aug, 06:30
KRX SM KRX SM
4,480. 00
+90
+2.0501%
111.77B Market Cap
- P/E Ratio
600% Div Yield
398,550 Volume
- Eps
4,390
Previous Close
Add Transaction
Day Range
4,300 4,700
Year Range
3,530 8,670
Want to track 253840 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

253840 trading today higher at ₩4,480, an increase of 2.0501% from yesterday's close, completing a monthly increase of 16.3636% or ₩630. Over the past 12 months, 253840 stock lost -28.8889%.
253840 is not paying dividends to its shareholders.
Sugentech Inc. has completed 1 stock splits, with the recent split occurring on Dec 07, 2018.
The company's stock is traded on one exchange.

253840 Chart

People also search for

Fine M-Tec Co., Ltd.
9,090
-0.7642%
Genexine Co., Ltd.
2,715
-0.1838%
TiumBio Co., Ltd.
4,915
-2.2863%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,250
+0.9825%

Sugentech Inc. (253840) FAQ

What is the stock price today?

The current price is ₩4,480.00.

On which exchange is it traded?

Sugentech Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 253840.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 600%.

What is its market cap?

As of today, the market cap is 111.77B.

Has Sugentech Inc. ever had a stock split?

Sugentech Inc. had 1 splits and the recent split was on Dec 07, 2018.

Sugentech Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
- CEO
KRX SM Exchange
KR7253840003 ISIN
KR Country
144 Employees
28 Dec 2022 Last Dividend
7 Dec 2018 Last Split
- IPO Date

Overview

Sugentech Inc., originally known as Accugen Healthcare, Inc., underwent a name change in October 2013 and has been operating under its new identity since then. Founded in 2011 and headquartered in Daejeon, South Korea, the company positions itself at the confluence of biotechnology, information technology, and nanotechnology. With a global reach, Sugentech Inc. specializes in developing and distributing in-vitro diagnostic systems and products. These innovations are designed to meet a variety of healthcare needs, from disease diagnostics to self-testing solutions, leveraging modern technology to deliver accurate results.

Products and Services

Sugentech Inc. offers a diverse portfolio of products and services, each tailored to address specific diagnostic and testing needs:

  • Multiplex BLOT Disease Diagnostic Devices: This range includes the immunoblot processor, with options for semi and full automation, and molecular diagnostic systems. These devices are geared towards disease diagnosis and are designed to handle multiple tests efficiently.
  • Self-Testing Products: Catering to the growing trend of self-care, Sugentech Inc. provides products such as digital ovulation and pregnancy tests, including tests for early pregnancy signs. These user-friendly products empower individuals to conduct their tests privately and conveniently.
  • Mobile Testing Products: Embracing the digital evolution in healthcare, Sugentech Inc. has developed mobile-connected testing products. These innovative solutions are designed for users seeking immediate test results through their mobile devices, offering convenience and accessibility.
  • Point of Care Testing Analyzers and Test Items: Sugentech Inc. supplies analyzers and test items for various point-of-care testing needs. These include the detection of M.tuberculosis, M.bovis, SARS-CoV-2 antibodies and antigens, flu A/B antigens, and CRP/hsCRP/dualCRP. Additionally, the products cater to measuring procalcitonin, troponin I, hemoglobinA1c, human chorionic gonadotropin, immunoglobulin E, and influenza A/B. This versatile range addresses the demands for quick, accurate healthcare diagnosis and monitoring, directly at the point of care.

Contact Information

Address: 206, Techno 2-ro
Phone: 82 4 2364 5001